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Objective: During routine noninvasive prenatal testing (NIPT), cell‐free fetal DNA
fraction is ideally derived from shallow‐depth whole‐genome sequencing data,
preventing the need for additional experimental assays. The fraction of aligned reads
to chromosome Y enables proper quantification for male fetuses, unlike for females,
where advanced predictive procedures are required. This study introduces PREdict
FetAl ComponEnt (PREFACE), a novel bioinformatics pipeline to establish fetal
fraction in a gender‐independent manner.
Methods: PREFACE combines the strengths of principal component analysis and
neural networks to model copy number profiles.
Results: For sets of roughly 1100 male NIPT samples, a cross‐validated Pearson
correlation of 0.9 between predictions and fetal fractions according to Y chromo-
somal read counts was noted. PREFACE enables training with both male and unla-
beled female fetuses. Using our complete cohort (nfemale = 2468, nmale = 2723), the
correlation metric reached 0.94.
Conclusions: Allowing individual institutions to generate optimized models side-
lines between‐laboratory bias, as PREFACE enables user‐friendly training with a
limited amount of retrospective data. In addition, our software provides the fetal
fraction based on the copy number state of chromosome X. We show that these
measures can predict mixed multiple pregnancies, sex chromosomal aneuploidies,
and the source of observed aberrations.1 | INTRODUCTION
Noninvasive prenatal testing (NIPT) has evolved into an important
routine clinical practice. Numerous variations on experimental and in
silico procedures have been shown to reliably detect fetal chromo-
somal aneuploidies, mostly concerning trisomies 13, 18, and 21.1-5- - - - - - - - - - - - - - - - - - - - - - - - - -
Creative Commons Attribution Li
by John Wiley & Sons LtdThe accuracy of NIPT seems high; however, as fetal fragments are
scattered throughout a more abundant maternal background in blood
plasma, individual performance highly depends on the fraction of fetal‐
derived cell‐free DNA (FF). Indeed, the minimal FF for reporting
unilateral conclusions has often been debated to be 4%, though lower
limits are alleged.6-8- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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What's already known about this topic?
• Cell‐free fetal DNA fraction is an important estimate
during noninvasive prenatal testing (NIPT).
• Most techniques to establish fetal fraction require
experimental procedures, which impede routine
execution.
What does this study add?
• PREFACE is a novel software to accurately predict fetal
fraction based on solely shallow‐depth whole‐genome
sequencing data, the fundamental base of a default
NIPT assay.
• In contrast to previous efforts, PREFACE enables user‐
friendly model training with a limited amount of
retrospective data.
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described to assess FF. Prior parental genomic information often
facilitates some of these procedures, as, eg, paternal or maternal
homozygous loci that are determined to be partly heterozygous in
maternal blood during pregnancy form a precise platform to quantify
FF.9-11 Nonetheless, parental priors are not always obliged: using
binomial mixture modeling, fetal and maternal clusters of single
nucleotide polymorphisms also reflect FF, yet a higher sequencing
depth is required.12 Likewise, different inputs, such as molecule size
(cell‐free fetal DNA fragments are often shorter) and methylation
patterns (some fetal sites are hypermethylated), enable FF
prediction.13-16
Routine NIPT is converging towards a cost‐effective recipe, with
back‐hand automated computational pipelines expecting mostly
single‐end shallow‐depth whole‐genome sequencing data (sWGS;
0.1‐1x coverage) to determine copy number alterations.17 Previously
discussed FF determining techniques imply the need for additional
laboratory steps and/or (currently) nonfeasible deep sequencing.
Therefore, a handful tools have been developed to predict FF
based on exclusively sWGS data. The copy number state of the X
chromosome, and especially the number of observed Y chromosomal
reads, form popular foundations to calculate FF—here, these are
referred to as fetal fraction based on chromosome X (FFX) and
fetal fraction based on chromosome Y (FFY), respectively.18,19 Unfor-
tunately, they are only informative for male fetuses. Accordingly,
two other approaches have been described to predict FF, without
relying on the gonosomes. One of these exploits nucleosome
positions, hypothesizing that shorter fetal fragments are caused by
differential nucleosome packaging.20 The spatial distribution of
mapped reads should represent FF; however, the reported
performance of the predictive model seems rather unsatisfactory.19
Finally, SeqFF, which uses a model designed directly on bin‐wise
copy number features of more than 25 000 pregnant women,
reports accurate FF determination, with a Pearson correlation
between predictions and FFY of 0.932.21 The inventors state that
cell‐free fetal and maternal fragments are not uniformly
distributed across the human reference genome: small differences
in local read counts are predictive for FF. Aside from the seemingly
excessive number of required male training samples, the software
does not provide a training option. Therefore, users are restricted
to a pretrained alternative. Because of inevitable differences in
laboratory and computational procedures between training and
test cases, the correlation is expected to be lower than what is
claimed.
Applying similar biological principles as used by SeqFF, we
set out to develop PREdict FetAl ComponEnt (PREFACE), a
software that enables model training, utilizing a limited amount of
data, which includes unlabeled female samples to maximize the
input. The semisupervised pipeline operates an initial unsupervised
phase, in the form of a principle component analysis (PCA), and a
subsequent supervised step, where a neural network (NN) weighs
the computed principle components (PCs) to model fetal‐induced
variance.2 | MATERIALS AND METHODS
2.1 | Library preparation and sequencing
Blood samples were collected in 10‐mL cell‐free DNA BCT tubes
(Streck) or PAXgene Blood DNA Tubes (Qiagen). Within 24 hours after
collection, plasma isolation was executed by centrifugation (4°C; 10
minutes at 1600 g; 10 minutes at 16 000 g, or 15 minutes at 1900
g, respectively). The supernatant was transferred to a new tube and
cfDNA was extracted from 3.5‐mL plasma using the Maxwell RSC
ccfDNA Plasma Kit (Promega), following the manufacturer's
instructions.
Using 25 μL of cfDNA, library preparation was executed on a
Hamilton Star liquid handler using the NEXTflex Cell Free DNA‐Seq
Library Prep Kit (Bioo Scientific) and NEXTflex DNA Barcodes (Bioo
Scientific). After pooling, cluster generation and sequencing were
completed by respectively a cBot 2 and HiSeq 3000 system (Illumina).
The minimal number of reads (single‐read; 50‐cycle mode) per sample
was set to 15 million.2.2 | Copy number profiling
Raw reads were mapped by Bowtie 2 onto human reference genome
GRCh38 (and GRCh37, for SeqFF compliance), using the fast‐local
flag.22 Biobambam's bamsormadup was used to mark duplicate
reads and to sort resulting bam files.23 Indexing was executed by
SAMtools.24 To reliably deduce normalized bin‐wise log2 ratios from
sWGS data, we preferred WisecondorX, considering it yields superior
copy number profiles, as shown by our group in earlier work.25 These
ratios represent the relation between the observed (numerator) and
expected (denominator) number of reads, the latter matching the dip-
loid state. Since these values are subject to Gaussian noise, a resolu-
tion of 100 kb was selected to yield reasonable noise levels in
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Regions without resulting information were interpreted as loci of
undeterminable copy number, as defined by WisecondorX.
2.3 | NIPT cohort
From December 2017 until September 2018, 5629 NIPT experiments
were routinely executed at the Center for Medical Genetics Ghent, of
which 5572 passed quality filtering, including 177 echographically
confirmed twins, one triplet, and 14 fetuses with confirmed trisomies
for chromosome 13, 18, or 21 by chorionic villus sampling or amnio-
centesis. All analyses were applied to this set, with the exception of
the actual model training and subsequent cross‐validation. For these
parts, we defined a second set (nfemale = 2468, nmale = 2723) after
applying an additional filter: exclusively gender‐annotated single and
same‐gender multiple pregnancies were allowed, where five more
male samples, suspected of having sex aberrations according to differ-
ences in FFY and SeqFF computations, were excluded.
2.4 | Response variable FFY
For male fetuses, the FF is linearly proportional to the read depth‐
corrected mean number of observed Y reads (YNIPT,male). In the formula
below, the prior or naive FFY is interpreted as a YNIPT,male observation
between the median of a set of male liquid biopsies (LBs) gYLB;male (FFY
= 100%) and female background noise gYNIPT;female (FFY = 0%). For
female fetuses, the prior FFY is set to 0.
FFYprior;male ¼ YNIPT;male −
gYNIPT;femalegYLB;male − gYNIPT;female (1)
FFYprior;female ¼ 0 (2)
As previously reported, masking the Y chromosome prior to calcu-
lating FFY increases the precision.18,19 We took this concept one step
further by creating a model that provides a weighted selection of the
most appropriate set of Y windows. This way, a large increase in
power to separate males from females was noted. We believe hyper-
variable FF‐unrelated bins are down‐weighted, forming a supposed
overall more accurate FFY. A general linear model with lasso regulari-
zation (λ = 1e−4) was selected, using the read depth‐normalized num-
ber of reads at 5 kb Y bins as explanatory parameters, and the prior
FFY as a response variable (Figure S1). The fitted model parameters
were retrieved to infer a final FFY, as shown below.
FFYfinal ¼ β0 þ β1y1 þ…þ βnyn (3)
Above, β0 is the intercept, βk indicates the beta estimate for bin k,
whereas yk represents the observed normalized number of reads at
the same locus. Chromosome Y has n bins (n = 11 447). Note that
FFYfinal was calculated using a cross‐validation strategy: different
models were trained to circumvent overlap between train and test
cases. An overall model determined that 10.76% of chromosome Yremained available for FFY determination (βk ≠ 0). The Pearson corre-
lation between the prior and final FFY was 0.985 for male fetuses.2.5 | PREFACE method
To maximize training input, PREFACE uses a combination of unsuper-
vised (applicable to all NIPT samples) and supervised learning (applica-
ble to samples with known FF, being all male fetuses in our case). The
explanatory variables comprise all autosomal bins for which a log2
ratio could be derived. Note that an exception holds: loci at
chromosomes 13, 18, and 21 are excluded—this is because these
chromosomes might be wrongly estimated as highly related to FF
due to the presence of fetal aneuploidies in the training set.2.5.1 | Unsupervised learning
Between observations (samples), some explanatory variables (bins) are
expected to be codependent as a result of inter alia differing FFs. In
other words, nonrandom variance, linked to FF, is thought to be pres-
ent. PCA is a technique to model the observed variance by orthogonal
transformation: the original explanatory variables are converted to
new linearly uncorrelated parameters, named PCs.26 PCs are ranked
in order of importance, meaning each PC explains less variance than
its predecessor. The first set of PCs (ndefault = 50) models a large por-
tion of the nonrandom variance, thus including FF‐induced variance,
whereas the remaining PCs mostly map naturally occurring Gaussian
noise, as a result of the original binomial read count distribution.27
The computed PCA rotations, based on all NIPT samples, enable us
to calculate the most important PCs for exclusively cases with known
FF. This latter set is further processed in the supervised phase.2.5.2 | Supervised learning
As stated, PCA presumably separates Gaussian noise from other
sources of variance. Consequently, a supervised classifier is required
to model exclusively FF‐induced variance. We preferred an artificial
NN with two hidden layers, using resilient backpropagation with
weight backtracking, and the sum of squared errors as a loss function.
This black box method weighs parameters (PCs) in function of the
response variable (FFY). As machine learning often tends to find the
best solution for most cases, rather than for all, predictions and FFY
values are slightly “slanted” relative to each other. A default slope
and intercept extracted from a linear model corrects for this tendency.2.6 | PREFACE software
The PREFACE software, written in R, is divided in two large compo-
nents: one for training and one for predicting (Figure 1). It is available
at https://github.com/CenterForMedicalGeneticsGhent/PREFACE.
FIGURE 1 Schematic representation of the
PREFACE software. The “train” component
(dark grey) accepts NIPT copy number profiles
from both male and female fetuses. A
predictive model is generated using all
provided samples. To gain insight in the
performance of this model, 10‐fold cross‐
validation is executed in addition. The
“predict” component (light grey) makes
predictions by applying the trained model to a
supplied copy number profile.
Abbreviations: CNP, copy number profile;
FFX, fetal fraction based on chromosome X;
FFY, fetal fraction based on chromosome Y;
MAE, mean absolute error; NIPT, noninvasive
prenatal testing; NN, neural network; OLM,
ordinary linear model; PCA, principal
component analysis; PREFACE, PREdict FetAl
ComponEnt; RLM, robust linear model; S, set
[Colour figure can be viewed at
wileyonlinelibrary.com]
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When feeding the train module copy number profiles in combination
with FFY measurements from male fetuses, a model is created as
described above. Since NNs can experience convergence problems,
and as they were noted to be less performant on small training sets,
an ordinary linear model (OLM) can alternatively be selected as a
classifier. Performance statistics are derived from a 10‐fold cross‐
validation technique: 10% of male samples are iteratively ignored dur-
ing training, followed by evaluating the correlation and mean absolute
error between FFY and predictions in the left‐out test set. In addition,
PREFACE fits a robust linear model (RLM) between the overall ratio
(observed/expected number of reads) of chromosome X and FFY,
enabling FFX calculations. A robust technique was favored to sideline
(mosaic) (sub)chromosomal maternal deviations during training.2.6.2 | Predicting
The predict component accepts a trained model and a NIPT copy num-
ber profile. Bins without information are replaced by interpolated
mean training values. PREFACE transforms bin‐wise values to PCs
using the PCA rotations and subsequently outputs the FF according
to the NN. The robust least squares fit is applied to chromosome X's
ratio to retrieve FFX.3 | RESULTS
3.1 | The PREFACE modeling strategy proves to be
powerful
Two important aspects should be evaluated to assess the competence
of our approach: the tightness of a relation is given by the Pearson
correlation (r), whereas the agreement between two methods can beexplored by both visual interpretation—by use of a least squares fit
and an identity line—and the mean absolute error (MAE).28
The PREFACE software was executed four times across pairwise
combinations between two data sets (male‐only NIPT samples; all
NIPT samples) and two classifiers (OLM; NN). In comparison, a state‐
of‐the‐art supervised elastic net was optimized in accordance to
Friedman et al, therefore exclusively trained with male fetuses.29
3.1.1 | Males
Cross‐validation indicates that PREFACE is superior to a traditional
elastic net (Table 1). The NN, default in PREFACE, performs generally
better than the optional OLM. Although the classifiers are trained with
male fetuses only, the inclusion of females during the unsupervised
phase significantly improves performance: the correlation between
predictions and FFY rises from 0.926 to 0.94, while the MAE drops
0.18 units—statistics emerging from the NN (Figure 2A,B). Indeed,
adding female samples (or in general, adding more samples) enables
the PCA algorithm to explain a larger proportion of (nonrandom) vari-
ance in its most important PCs (Figure S2). Although NNs perform
generally better, users can opt for an OLM instead, as these tend to
be more reliable on smaller data sets (Figure S3). For sets of roughly
1100 male samples, a correlation of 0.9 is reached.
3.1.2 | Females
Since NIPT samples from female fetuses lack independent FF mea-
surements, PREFACE values were compared with SeqFF predictions,
an approach proven to be applicable to female cases. Two major con-
clusions could be drawn. First, for males, the correlation between FFY
and SeqFF predictions is “only” 0.887, lower than the reported 0.932,
thus presumably caused by experimental differences between the
pretrained SeqFF model and FFY (Figure S4a).21 Moreover, the least
squares fit is considerably less steep than the identity line, showing
that SeqFF claims mostly higher FFs. Second, applying the female
FIGURE 2 Performance evaluation of the PREFACE method. A, A scatter plot reveals highly correlated (r) FFY and PREFACE predictions.
Moreover, the OLS fit largely covers the identity line. B, A histogram visualizes normally distributed errors centered around 0 and a low MAE
between predictions and FFY. C, Scattered symbols indicate reported NIPT samples with aneuploidies. The dotted line represents an OLS fit
between the PREFACE values and the mean log2 ratio of the corresponding structural validated events. Where confirmed aberrations are highly
concordant to FF predictions, nonconfirmed aneuploidies are randomly scattered. Abbreviations: OLS, ordinary least squares; MAE, mean absolute
error; FF, fetal fraction; FFY, fetal fraction based on chromosome Y; NIPT, noninvasive prenatal testing; PREFACE, PREdict FetAl ComponEnt
[Colour figure can be viewed at wileyonlinelibrary.com]
TABLE 1 Cross‐validation to compare combinations of classifiers and training sets
Note. Next to four setups applicable to the PREFACE software, a traditional elastic net was optimized to support comparison. A model initialized with
default arguments, trained using NIPT samples from both male and female fetuses, enables the most accurate predictions, measured by Pearson correlation
and MAE. The MAE for the lowest FFs (<10%) is shown separately. Although multicore processing is optional, timing was performed on a system equipped
with a 2.3 GHz Intel Core i5 processor using only a single thread. Abbreviations: MAE, mean absolute error; FF, fetal fraction; NIPT, noninvasive prenatal
testing; PCA, principal component analysis; PREFACE, PREdict FetAl ComponEnt.
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SeqFF of 0.895 (Figure S4b). As expected, a similar yet inverse incon-
sistency with the identity relation is retrieved, validating PREFACE's
applicability to female fetuses.3.1.3 | Fetal fraction based on chromosome X
The relation between FFX and FFY seems trivial. Therefore, the PREF-
ACE software solely fits an RLM to the provided male fetuses without
executing cross‐validation. A weighted correlation as high as 0.971
supports this approach (Figure S5).30 Extreme outliers are caused by
(mosaic) (sub)chromosomal maternal rearrangements, illustrating the
need for a robust model.3.2 | There is a strong correlation between FF
predictions and confirmed aneuploidies
Throughout the NIPT cohort, 14 fetuses were reported with con-
firmed aneuploidies. These involve two cases with Patau syndrome
(trisomy 13), one with Edward syndrome (trisomy 18), and 11 with
Down syndrome (trisomy 21). Unconfirmed aneuploidies (after amnio-
centesis) include, eg, nonviable trisomies 7, 14, and 20, representing
aberrations that are likely mosaicisms confined to the placenta.
Another reported abnormality, concerning trisomy 21, was shown to
be unrelated to the fetus by amniocentesis.
Fetal‐derived nonmosaic aberrations are expected to have an
amplitude proportional to the FF (1,6,7). Hence, prior to the execution
of an invasive assay, predictions on FF suggest the source of a
930 RAMAN ET AL.potential aneuploidy. This is shown by a compelling concordance
between the mean log2 ratio of confirmed whole‐chromosome dupli-
cations and predictions of r = 0.959, additionally indicating PREFACE's
accuracy (Figure 2C). Where the amplitudes of fetal abnormalities are
positioned to expectation, defined as in Adalsteinsson et al, nonfetal
observations are randomly scattered (Figures S6 and S7).31 Here, the
difference between the expected FF (based on confirmed aberrations)
and predicted FF (according to PREFACE) is characterized by a
standard deviation of 1.92%.
3.3 | PREFACE empowers gender prediction in
multiple pregnancies
Besides single pregnancies, the NIPT cohort includes 177 twins,
established through ultrasonography. The ratio between FFY and true
FF naturally provides information about the gender of each fetus: two
males are theoretically characterized by a ratio of 1; while with female
twins, this measure amounts to 0, whereas for mixed pregnancies, a
close‐to 0.5 ratio is expected.
Our cohort contains both confirmed (by birth) and unconfirmed
twin genders. The density distribution of the ratio between FFY and
FF intrinsically represents the ability to distinguish different combina-
tions of genders. Using Gaussian mixture modeling, three distinct
peaks are retrieved across twins lacking gender confirmation
(Figure 3A). This suggests that female twins can be categorized with
high accuracy, yet, discriminating male‐male from male‐female twins
remains difficult for pregnancies with low FF (Figure 3B). Finally, a
similar visualization, holding validated genders, does confirm the
reliability of this technique (Figure 3C).3.4 | PREFACE indirectly hints towards potential sex
aneuploidies
With PREFACE, FFY, and FFX, three methods have been presented to
establish FF. A consequence of adopting these estimates—next toFIGURE 3 Gender prediction in twins. A, Including twins without confirm
fits the FFY/PREFACE density distribution well. The expected local minim
gender. B, A scatter visualization plots the PREFACE predictions in functio
represent the theoretical expectation. Pearson correlations (r) are given. C
Thick dotted lines represent the cutoffs from (A). Colors are defined by act
PREFACE, PREdict FetAl ComponEnt [Colour figure can be viewed at wilewhat has already been discussed—is the inherent information on sex
aneuploidies they potentially reveal. Sex aneuploidies were until now
not reported by our institution; therefore, none are confirmed,
meaning this final section is purely indicative and further experimental
validation is warranted.
A dual modeling strategy was developed. First, by simultaneously
comparing both FFX and FFY to PREFACE predictions, the power to
distinguish genders increases.





Second, most frequent sex aneuploidies, including Turner (X),
triple‐X (XXX), Klinefelter (XXY), and XYY syndrome, are theoretically
captured by directly subtracting FFY with FFX, independent from
gender.
Density 2i ¼ ∑ij¼0 FFYj − FFXj
 
(5)
Eight FFX outliers (less than −40%; greater than 40%), caused by
maternal aberrations, were removed prior to fitting Gaussian (mixture)
models to analytically describe the density distributions, expecting
three (males, females, and mixed twins) and one component(s),
respectively (Figure 4A,B). Optimally, the results are presented in a
three‐dimensional all‐inclusive figure, plotting FFY, FFX, and PREF-
ACE values along its axes (File S1). Here, we opted to visualize the
results in accordance to two preferred viewpoints (Figure 4C,D). It is
notable that confirmed twins are highly enriched in the middle
Gaussian component of Density 1: these are mixed twin pregnancies.
In total, 39 (0.71%) cases significantly deviate from the healthy FFY‐
FFX trend. The majority of these likely concern (mosaic) maternal
events and a few suspected subchromosomal aberrations. However,
four XXY, two XYY, one XXX, and none X fetuses seem to be present
when evaluating the FFX‐FFY outliers in function of the PREFACE
predictions (Figure S8). Worth saying, these numbers largely corre-
spond to reported incidence.32-35ed genders, a Gaussian mixture model, expecting three components,
a (at one‐fourth and three‐fourth) represent cutoffs to predict fetal
n of FFY. Colors are defined by previous cutoffs. Thick dotted lines
, Evaluation of this method using confirmed (by birth) twin genders.
ual gender. Abbreviations: FFY, fetal fraction based on chromosomeY;
yonlinelibrary.com]
FIGURE 4 Modeling of FFY, FFX, and PREFACE measures to predict mixed twins and sex aneuploidies. A, Density Gaussian mixture modeling to
map fetal gender. The color gradient is linearly assigned in accordance to the component's means. Outliers are shown in grey. B, A Gaussian
distribution is fitted to appoint outliers, where the latter is defined as such once it deviates with more than 3 standard deviation units from the
mean. C, FFY‐FFX‐PREFACE viewpoint 1. Colors are defined by (A); dots and squares represent confirmed single and twin pregnancies, respectively;
plusses overrule previous symbols, as determined by (B). As expected, it is notable that red symbols are highly enriched with twins, especially for
higher FFs. D, FFY‐FFX‐PREFACE viewpoint 2. Colors and symbols are defined in analogy to (C). Outliers likely correspond to maternal events or
fetal sex aneuploidies. Abbreviations: FF, fetal fraction; FFX, fetal fraction based on chromosome X; FFY, fetal fraction based on chromosome Y;
PREFACE, PREdict FetAl ComponEnt [Colour figure can be viewed at wileyonlinelibrary.com]
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Recent technological advancements improved genetic testing
dramatically. While the economic feasibility of whole‐genome
sequencing keeps progressing, the accuracy of fetal aneuploidy detec-
tion is at an ever‐high: sWGS studies commonly report near 0.99
sensitivity/specificity for Patau, Edward, and Down syndrome detec-
tion.8,36 As a consequence, noninvasive screening is no longer con-
fined to high‐risk groups but is gradually more generally executed.
Large NIPT turnovers produce an abundance of retrospective use-
ful data. One interesting application enabled by these quantities is
machine learning, as, eg, FF, a particularly important figure during
testing, can be estimated based on copy number data. Predictive
models are ideally trained with in‐house profiles to suppress
between‐laboratory procedural bias. Notwithstanding, sufficient data
are frequently present at these institutions; to date, an accurate auto-
mated learning software does not exist. Therefore, we developed
PREFACE, a user‐friendly tool to model and predict FF without thenecessity of prior mathematical know‐how on predictive modeling.
The inclusion of unlabeled samples for training, which significantly
contributes to an increased overall performance, introduces another
novelty to this field.
Using less than 5000 training samples, predictions made by PREF-
ACE were highly concordant to FFY, indicated by a Pearson correla-
tion of 0.94. To our knowledge, starting from sWGS data only, no
software has been reported to perform better. Next to traditional
cross‐validation, PREFACE was evaluated by SeqFF comparison (for
female fetuses); by density Gaussian mixture modeling across twins;
and by aneuploid fetuses, where the log2 ratio of confirmed events
was found to be highly concordant with FF (r = 0.959).
Since the SeqFF trend was not in satisfying agreement with FFY
(SeqFF claims mostly higher FFs), one could wonder which of both
variables is truly biased. Accordingly, not presented in the results, we
computed FFY and FFX for six liquid biopsies and six lymphocyte‐
extracted genomic DNA samples, obtaining percentage estimations
ranging within {98, 103} and {−1, 1} for males and females,
932 RAMAN ET AL.respectively. Moreover, PREFACE's model, trained on FFY, yields pre-
dictions that are conform with confirmed trisomies (Figures S6 and
S7). The pretrained SeqFF model is therefore more likely to be biased
rather than FFY.
The success of the modeling approach is thought to involve three
main pillars. First, we believe that the FFY measure, although hard to
prove, is accurate. Masking parts of chromosome Y prior to predicting
FF has been cited to increase correctness.18,19 Due to sequence simi-
larities with other chromosomes (eg, the pseudoautosomal region) and
technological limitations of short‐read mapping (repeats, variable
regions of mappability, GC content, etc), numerous Y loci are indeed
ambiguous.37,38 Instead of solely categorizing bins as informative and
noninformative, we reasoned that the informative bins also differ in
their “level of male specificity,” thereby encouraging the idea of a
bin‐wise weighted contribution to FFY. Second, read count normaliza-
tion was executed by WisecondorX, a sophisticated within‐sample
normalization procedure, which supposedly delivers superior pro-
files.25 And last but not least, the nature of the modeling strategy
maximizes training input by allowing unlabeled samples.
Gonosomal aberrations are theoretically exposed during NIPT in a
similar way as any other aneuploidy. Nevertheless, the specificity is
reported to be much lower in comparison with traditional screening
of chromosomes 13, 18, and 21, especially for monosomy X.39-41
Ethical issues on reporting these sometimes nonsevere abnormalities
aside, the incorporation of FF in statistical outcome—which is gener-
ally not done with, eg, the popular z‐score approach—does improve
performance.42,43 Indeed, our study was concluded by revealing that
0.71% of all NIPT samples significantly differed from the healthy
gonosomal trend; however, when evaluating these outliers in relation
to predicted FF, only a few truly met the requirements to suffice as
being potentially sex aneuploid.
The convenience by which PREFACE could be implemented in
existing NIPT pipelines seems undeniable: a copy number profile, the
fundamental base of an assay, is singly requisite as input. This paper
extensively demonstrates the practical value of accurate FF estima-
tions on real data collected over the course of nine months. We
believe PREFACE and the elaborated FF methodologies could be
useful to many NIPT laboratories, evidentially motivating this work.CONFLICT OF INTEREST
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